SCHEMBL27451424

SCHEMBL27451424

O=C(CCN1C(=O)CCC1O)Nc1ccc(-c2nc3ccccc3s2)nc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.49
▸ NPC1 O15118 5/20 0.49
▸ RAB9A P51151 5/20 0.49
▸ MEN1 O00255 4/20 0.49
▸ KMT2A Q03164 4/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ PSMD14 O00487 1/20 0.46
▸ MGLL Q99685 10/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ HPGD P15428 2/20 0.43
▸ TP53 P04637 2/20 0.43
▸ ADRB2 P07550 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ PKM P14618 1/20 0.42
▸ NFKB1 P19838 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ NFKB2 Q00653 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27451347 0.88 RAB9A (0.64) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL27451505 0.85 NPC1 (0.59) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL31050189 0.85 NPC1 (0.59) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL31050188 0.85 NPC1 (0.59) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL27451353 0.76 NPC1 (0.64) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL31050186 0.72 RAB9A (0.48) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL27451289 0.72 MAPT (0.53) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL27451116 0.72 RAB9A (0.77) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL27452497 0.72 MEN1 (0.61) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL27451351 0.71 RAB9A (0.68) MAPTNPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024145662-A1 2-SUBSTITUTED THIAZOLE AND BENZOTHIAZOLE COMPOSITIONS AND METHODS AS DUX4 INHIBITORS ALTAY THERAPEUTICS, INC. (US) 2024-07-04 — — WO disclosed
Send feedback